Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Share-based Compensation: 2010-2019

Historic Share-based Compensation for EyePoint Pharmaceuticals (EYPT) over the last 8 years, with Dec 2019 value amounting to $780,000.

  • EyePoint Pharmaceuticals' Share-based Compensation fell 32.35% to $780,000 in Q4 2019 from the same period last year, while for Dec 2019 it was $4.6 million, marking a year-over-year increase of 15.15%. This contributed to the annual value of $36.7 million for FY2024, which is 204.72% up from last year.
  • According to the latest figures from Q4 2019, EyePoint Pharmaceuticals' Share-based Compensation is $780,000, which was down 37.00% from $1.2 million recorded in Q1 2019.
  • In the past 5 years, EyePoint Pharmaceuticals' Share-based Compensation registered a high of $1.4 million during Q3 2018, and its lowest value of $396,000 during Q4 2016.
  • For the 3-year period, EyePoint Pharmaceuticals' Share-based Compensation averaged around $859,800, with its median value being $731,000 (2017).
  • Data for EyePoint Pharmaceuticals' Share-based Compensation shows a peak YoY increase of 179.46% (in 2019) and a maximum YoY decrease of 32.35% (in 2019) over the last 5 years.
  • EyePoint Pharmaceuticals' Share-based Compensation (Quarterly) stood at $483,000 in 2015, then decreased by 18.01% to $396,000 in 2016, then skyrocketed by 53.03% to $606,000 in 2017, then soared by 90.26% to $1.2 million in 2018, then plummeted by 32.35% to $780,000 in 2019.
  • Its Share-based Compensation was $780,000 in Q4 2019, compared to $1.2 million in Q1 2019 and $1.2 million in Q4 2018.